JENNIFER CHAMBERLAIN: Open Payments
NPI 1255914859 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 66 payments from 10 companies in 2025. Trend: 2023 $265 · 2024 $140 · 2025 $1,343
Food & beverage: $1,158Education: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $264 |
| Novartis Pharmaceuticals Corporation | 17 | $234 |
| Janssen Biotech, Inc. | 9 | $233 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $169 |
| GENZYME CORPORATION | 5 | $139 |
| Lilly USA, LLC | 6 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| UCB, Inc. | 2 | $60 |
| PFIZER INC. | 1 | $24 |
| Incyte Corporation | 1 | $14 |
Products named: COSENTYX, TREMFYA, DUPIXENT, SKYRIZI, TALTZ, RINVOQ, ILUMYA, Bimzelx.
Industry payments across NY — which companies pay providers there.
